Rueil Malmaison, France

Ives R Pascal


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ives R. Pascal: Pioneering Benzodiazepines

Introduction

Ives R. Pascal, a prominent inventor based in Rueil Malmaison, France, has made significant contributions to the field of pharmaceuticals. With a dedication to research and innovation, he has managed to secure a patent that stands out in the area of benzodiazepine compounds.

Latest Patents

Ives R. Pascal is the inventor of a notable patent titled "Benzodiazepines, Process and Intermediates for the Preparation Thereof." This patent involves benzodiazepines represented by a complex formula where R₁ can be hydrogen or halogen, R₂ is either hydrogen or halogen, and Ar includes various aromatic groups such as indolyl, phenyl, and naphthyl structures. The patent also addresses their optical isomers, showcasing the versatility of these compounds in pharmaceutical applications.

Career Highlights

Currently associated with Jouveinal S.A., Ives R. Pascal has demonstrated an unwavering commitment to advancing medicinal chemistry. His work on benzodiazepines has provided essential processes and intermediates that enhance the efficacy and production of these significant therapeutic agents, which are widely used for their anxiolytic and sedative properties.

Collaborations

Throughout his career, Ives has collaborated with esteemed colleagues such as Alain P. Calvet and Jean-Louis Junien. These partnerships have likely contributed to the richness of his work and opened pathways to new innovations within the pharmaceutical sector.

Conclusion

Ives R. Pascal's patent and collaborative efforts represent a remarkable contribution to the field of pharmaceutical research. His inventive spirit and dedication to his craft are evident in his work, and his innovative solutions continue to influence the development of essential therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…